In BrainQ, I've developed a therapeutic device that have shown to increase rehabilitation process in animal model after stroke, SCI, and TBI, where the major phenomena was to regenerate white matter of specific neural networks that lead to re-gaining lost functions. However, one of the main questions is the rate of degeneration of axons after stroke. In our paper we can see that after stroke, 2 weeks later to the stroke, the rat (stroke side) CC is invisible in the MRI/DTI image. I be be grateful to hear your opinion on this mater, which reflect on treatment of people after stroke.
did you know these studies ?
and could you tell me what is BrainQ ?
https://www.ncbi.nlm.nih.gov/pubmed/18216462
https://www.ncbi.nlm.nih.gov/pubmed/23395544
https://www.ncbi.nlm.nih.gov/pubmed/15654022
Dear Emmanuelle
BrainQ is a company that was created to resolve neurological deficits by means of enhancing natural rehabilitation processes of neural networks. It started where my son, Lear, was born with a rare genetic disorder that affect the CNS. In the process of understanding what is his exact "problem" I've discovered that many other nervous syndromes and impairments share similar characteristics to my son syndrome. Then I've developed a conceptual model for intensify rehabilitation processes in the brain (and spinal cord). Once pre-clinical trials have shown first signs that the concept is feasible, BrainQ (Brain cue to cure) was formed. The principle of the treatment is a very low intensity and frequency electromagnetic stimulation which sync to the way neural networks work, and by that, promote their re-growth, and by that, increase the chances and extent of rehabilitation after impairment. Since BrainQ have showed very impressive pre-clinical results (TBI, Stroke, SCI), BrainQ, as a compaby was formed. Right now we are conducting a clinical trial that is focused on spinal cord injury (were he people are about 6 months and longer after the injury, which brought me to ask how "post acute" .vs. "chronic" are they). We are seeking collaboration with researchers who are interested in clinical trials. We have published two papers about Stroke and SCI, and now in the process of publishing our paper about TBI.
- Badges
- Science topic